Highlights Ludwig Enterprises, Inc.

Equities

LUDG

US54973P4019

Market Closed - OTC Markets Other stock markets 20:43:50 31/05/2024 BST			5-day change	1st Jan Change
0.21 ^USD	+11.70%		+5.00%	+54.98%

05-20	Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-16	Ludwig Enterprises, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-20	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-16	CI
Ludwig Enterprises Inc. Enters Booming Artificial Intelligence Cancer Screening Market with Its Non-Invasive Cancer Diagnostics Testing Kit, Launching Within 2024	03-19	CI
Ludwig Enterprises Inc. Announces Patent Filing for Breakthrough in Identifying Mrna Genes Associated with Certain Cancers	03-06	CI
Ludus Enterprises, Inc. Receives Continuing Review Approval on Planned Clinical Study from Advarra IRB, Columbia, MD	01-31	CI
Ludwig Enterprises, Inc. Announces Executive Changes	12-01	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-28	CI
Ludwig Enterprises, Inc. Appoints Scott Silverman as Chief Financial Officer	11-16	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	18/08/23	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	21/06/23	CI
Ludwig Enterprises Announces Launches of New Nutraceutical and Strategic Marketing Plan	25/04/23	CI
Ludwig Enterprises Launches Nugenea, Groundbreaking Nutraceutical to Fight Inflammation	12/04/23	CI
Ludwig Enterprises, Inc. Receives Institutional Review Board Approval on Bladder Cancer Study	03/01/23	CI
Ludwig Enterprises Files A Patent That Could Be A Major Technology Breakthrough in Healthcare	22/09/22	CI
Ludwig Enterprises and Emerson Urology Associates Plan Bladder Cancer BCG Immunotherapy Study	20/09/22	CI
Ludwig Enterprises, Inc. acquired Direct Mortgage Investors, Inc.	18/12/19	CI
Ludwig Enterprises Inc. acquired Floss Publishing, Inc.	23/04/14	CI
Ludwig Enterprises, Inc., Opens Acquisition Talks With Floss Publishing, Inc.	03/03/14	CI
Ludwig Enterprises Inc. Announces Joint Venture Agreement with Worthington Financial Services, Inc	17/10/12	CI
Ludwig Enterprises Inc. Announces Definitive Agreement for Technology Deployment in South Korea	31/07/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Ludwig Enterprises, Inc.

Equities

LUDG

US54973P4019

Highlights

Filters